Table 1.
Baseline characteristics of the study participants by race and cohort.
| N | White | Black | ||
|---|---|---|---|---|
| MIPS | MIMS2 | MIPS | MIMS2 | |
| 337 | 42 | 111 | 90 | |
| Age (years), mean (SD) | 65 (9) | 50 (8.7) | 60(8) | 50 (7) |
| Male, % | 84 | 54 | 66 | 38 |
| BMI, (kg/m2), mean (SD) | 29 (5) | 29 (5) | 31 (5) | 33 (8) |
| Dyslipidemia, % | 83 | 63 | 86 | 65 |
| Ever smoking, % | 59 | 38 | 67 | 55 |
| Diabetes, % | 30 | 15 | 43 | 35 |
| Depression, % | 11 | 26 | 14 | 35 |
| Beta Blockers Use, % | 70 | 45 | 85 | 69 |
| CAD severity (stenosis ≥ 50%), % | 79 | 90 | 74 | 85 |
| Prior myocardial infarction, % | 33 | 100 | 31 | 100 |
| Heart failure, % | 20 | 2.4 | 35 | 9 |
| sPAT-ratio, mean (SD) | 0.71(0.31) | 0.82 (0.60) | 0.71 (0.38) | 0.84 (0.54) |
| Ejection Fraction, mean (SD) | 55 (13) | 51.8 (9.2) | 54(16) | 52.5 (12.4) |
BMI, body mass index; CAD, coronary artery disease; sPAT-ratio, stress-rest peripheral arterial tonometry, SD, standard deviation.
* PAT Effect due to SNP (p value).